Dallas’ Mary Kay Foundation, a longtime leader in the charge to eliminate cancers that affect women, donated $150,000 to CancerCare, the leading nonprofit that offers free financial and professional services to cancer patients.
The grant will allow CancerCare to provide direct support to women who are most in need of assistance. The organization aims to ensure that women largely from vulnerable, medically underserved populations receive the care they need.
It’s a necessary contribution, especially during the pandemic. COVID has caused a number of women with significant need but a limited access to resources to suffer from health and well-being issues.
“The COVID-19 crisis has caused an even greater burden to women facing a cancer diagnosis, especially those in underserved parts of our country where access to affordable treatment options were scarce to begin with,” CancerCare CEO Patricia Goldsmith said in a news release. “In addition, our clients are struggling with the financial and emotional toll, social isolation, lack of transportation, and countless other logistics. CancerCare is grateful to The Mary Kay Foundation for providing assistance to cover these indirect costs for the women and families we serve.”
The Mary Kay Ash Foundation has, over more than two decades, awarded more than $80 million to women’s shelters, domestic violence service providers, and cancer research programs throughout the U.S. It’s guided by Mary Kay Cosmetics Founder Mary Kay Ash’s dream to “enrich the lives of women everywhere.”
“Mary Kay is wholeheartedly committed to eradicating cancers affecting women, investing millions in innovative cancer research and support services annually,” Dr. Lucy Gildea, chief scientific officer at Mary Kay, said. “We realize this is a long-term goal, which is why we continue to partner with critical nonprofits providing support to those affected in the meantime. CancerCare provides relief to those most deeply impacted by a cancer diagnosis from the financial burden to the emotional toll it can take on an individual and family. We are honored to support their efforts.”
For more Forces for Good, go here.
Get on the list.
Dallas Innovates, every day.
Sign up to keep your eye on what’s new and next in Dallas-Fort Worth, every day.
R E A D N E X T
-
The pop-up digital showroom is a 360-degree, 3D beauty experience
-
JUNO, which has key executives in Dallas and other cities across the country, wants to get ahead of the hybrid event trend by offering event planners "Intersections of Connectivity," a free ebook on how to organize something that connects virtual participants and an in-person audience.
-
The investment was led by Advantech Capital, a PE fund based in China that focuses on TMT, pharmaceuticals, and healthcare. This combined with the support from the Cancer Prevention and Research Institute of Texas (CPRIT), which granted OncoNano $9.97 million last year, will support Phase 3 clinical trials for the biotech's technology that can diagnose and treat cancer with high specificity.
-
UNT hopes its cloud-based computer program called RE-PLAN will be able to solve equitable distribution issues that often accompany a speedy rollout. The technology, which uses sourced data to allow public health agencies to craft response plans, will be dispensed with an urgency to target special demographics communities, like people who have disabilities, don't speak English, and don't have cars.
-
Southlake-based OncoNano Medicine uses pH-sensitive nanoparticle technology to "light up" cancer for real-time surgical imaging. The multi-year collaboration will seek to uncover new cancer therapies that can benefit from OncoNano's technology. OncoNano raised $50 million in Series B funding in June.
